Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AKT interacting protein pseudogene (ENSG00000258681, LOC100128373) is a non-coding pseudogene in the human genome situated on chromosome 14. Pseudogenes like this one are genomic sequences resembling known genes (in this case, the AKTIP gene) but are generally non-functional, not producing protein. The actual AKTIP protein interacts with the serine/threonine kinase AKT and modulates its activity; however, the pseudogene does not encode a functional protein nor participate in biological processes or disease pathways. There is no evidence supporting its use as a therapeutic target or clinical biomarker, and it does not interact with drugs nor present safety concerns relevant to clinical pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AKT interacting protein pseudogene.